| Ident. | Authors (with country if any) | Title |
|---|
| 000032 (2020) |
Ming Niu [République populaire de Chine] ; Rui-Lin Wang [République populaire de Chine] ; Zhong-Xia Wang [République populaire de Chine] ; Ping Zhang [République populaire de Chine] ; Zhao-Fang Bai [République populaire de Chine] ; Jing Jing [République populaire de Chine] ; Yu-Ming Guo [République populaire de Chine] ; Xu Zhao [République populaire de Chine] ; Xiao-Yan Zhan [République populaire de Chine] ; Zi-Teng Zhang [République populaire de Chine] ; Xue-Ai Song [République populaire de Chine] ; En-Qiang Qin [République populaire de Chine] ; Jia-Bo Wang [République populaire de Chine] ; Xiao-He Xiao [République populaire de Chine] | [Rapid establishment of traditional Chinese medicine prevention and treatment of 2019-nCoV based on clinical experience and molecular docking]. |
| 000115 (2020) |
B. Coutard [France] ; C. Valle [France] ; X. De Lamballerie [France] ; B. Canard [France] ; N. G. Seidah [Canada] ; E. Decroly [France] | The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade |
| 000151 (2020) |
Peter P. Liu [Canada] ; Alice Blet [France] ; David Smyth [Canada] ; Hongliang Li [République populaire de Chine] | The Science Underlying COVID-19: Implications for the Cardiovascular System. |
| 000185 (2020) |
Rameez Jabeer Khan [Inde] ; Rajat Kumar Jha [Inde] ; Gizachew Muluneh Amera [Inde] ; Monika Jain [Inde] ; Ekampreet Singh [Inde] ; Amita Pathak [Inde] ; Rashmi Prabha Singh [Inde] ; Jayaraman Muthukumaran [Inde] ; Amit Kumar Singh [Inde] | Targeting SARS-CoV-2: a systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2'-O-ribose methyltransferase. |
| 000219 (2020) |
Samuel James Brake [Australie] ; Kathryn Barnsley [Australie] ; Wenying Lu [Australie] ; Kielan Darcy Mcalinden [Australie] ; Mathew Suji Eapen [Australie] ; Sukhwinder Singh Sohal [Australie] | Smoking Upregulates Angiotensin-Converting Enzyme-2 Receptor: A Potential Adhesion Site for Novel Coronavirus SARS-CoV-2 (Covid-19). |
| 000260 (2020) |
Rafal Butowt [Pologne] ; Katarzyna Bilinska [Pologne] | SARS-CoV-2: Olfaction, Brain Infection, and the Urgent Need for Clinical Samples Allowing Earlier Virus Detection. |
| 000317 (2020) |
Ashleigh Shannon [France] ; Nhung Thi Tuyet Le [France] ; Barbara Selisko [France] ; Cecilia Eydoux [France] ; Karine Alvarez [France] ; Jean-Claude Guillemot [France] ; Etienne Decroly [France] ; Olve Peersen [États-Unis, France] ; Francois Ferron [France] ; Bruno Canard [France] | Remdesivir and SARS-CoV-2: structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites |
| 000367 (2020) |
Tao Zhang [République populaire de Chine] ; Qunfu Wu [République populaire de Chine] ; Zhigang Zhang [République populaire de Chine] | Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak. |
| 000400 (2020) |
Xiaolong Tian [République populaire de Chine] ; Cheng Li [République populaire de Chine] ; Ailing Huang [République populaire de Chine] ; Shuai Xia [République populaire de Chine] ; Sicong Lu [République populaire de Chine] ; Zhengli Shi [République populaire de Chine] ; Lu Lu [République populaire de Chine] ; Shibo Jiang [République populaire de Chine] ; Zhenlin Yang [République populaire de Chine] ; Yanling Wu [République populaire de Chine] ; Tianlei Ying [République populaire de Chine] | Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody. |
| 000469 (2020) |
Hasanain Abdulhameed Odhar [Iraq] ; Salam Waheed Ahjel [Iraq] ; Ali A. Mohammed Ali Albeer [Iraq] ; Ahmed Fadhil Hashim [Iraq] ; Ali Mahmood Rayshan [Iraq] ; Suhad Sami Humadi [Iraq] | Molecular docking and dynamics simulation of FDA approved drugs with the main protease from 2019 novel coronavirus |
| 000694 (2020) |
Hong-Long Ji [États-Unis] ; Runzhen Zhao [États-Unis] ; Sadis Matalon [États-Unis] ; Michael A. Matthay [États-Unis] | Elevated Plasmin(ogen) as a Common Risk Factor for COVID-19 Susceptibility. |
| 000720 (2020) |
Han Ju [République populaire de Chine] ; Siyu Xiu [République populaire de Chine] ; Xiao Ding [République populaire de Chine] ; Min Shang [République populaire de Chine] ; Ruifang Jia [République populaire de Chine] ; Bing Huang [République populaire de Chine] ; Peng Zhan [République populaire de Chine] ; Xinyong Liu [République populaire de Chine] | Discovery of novel 1,2,3-triazole oseltamivir derivatives as potent influenza neuraminidase inhibitors targeting the 430-cavity. |
| 000889 (2020) |
Kamal Kant Sahu [Oman] ; Ajay Kumar Mishra [Oman] ; Amos Lal [Oman] | COVID-2019: update on epidemiology, disease spread and management. |
| 000953 (2020) |
B. Robson | COVID-19 Coronavirus spike protein analysis for synthetic vaccines, a peptidomimetic antagonist, and therapeutic drugs, and analysis of a proposed achilles’ heel conserved region to minimize probability of escape mutations and drug resistance |
| 000971 (2020) |
Siu-Ying Lau [République populaire de Chine] ; Pui Wang [République populaire de Chine] ; Bobo Wing-Yee Mok [République populaire de Chine] ; Anna Jinxia Zhang [République populaire de Chine] ; Hin Chu [République populaire de Chine] ; Andrew Chak-Yiu Lee [République populaire de Chine] ; Shaofeng Deng [République populaire de Chine] ; Pin Chen [République populaire de Chine] ; Kwok-Hung Chan [République populaire de Chine] ; Wenjun Song [République populaire de Chine] ; Zhiwei Chen [République populaire de Chine] ; Kelvin Kai-Wang To [République populaire de Chine] ; Jasper Fuk-Woo Chan [République populaire de Chine] ; Kwok-Yung Yuen [République populaire de Chine] ; Honglin Chen [République populaire de Chine] | Attenuated SARS-CoV-2 variants with deletions at the S1/S2 junction. |
| 000994 (2020) |
David Gurwitz [Israël] | Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics. |
| 000A34 (2020) |
Meng Yuan [États-Unis] ; Nicholas C. Wu [États-Unis] ; Xueyong Zhu [États-Unis] ; Chang-Chun D. Lee [États-Unis] ; Ray T. Y. So [République populaire de Chine] ; Huibin Lv [République populaire de Chine] ; Chris K. P. Mok [République populaire de Chine] ; Ian A. Wilson [États-Unis] | A highly conserved cryptic epitope in the receptor-binding domains of SARS-CoV-2 and SARS-CoV |
| 000B21 (2019) |
Yichao Wan [République populaire de Chine] ; Yuanhua Li [République populaire de Chine] ; Chunxing Yan [République populaire de Chine] ; Mi Yan [République populaire de Chine] ; Zilong Tang [République populaire de Chine] | Indole: A privileged scaffold for the design of anti-cancer agents. |
| 000B45 (2019) |
Kouji Ohnishi [Japon] ; Yasunao Hattori [Japon] ; Kazuya Kobayashi [Japon] ; Kenichi Akaji [Japon] | Evaluation of a non-prime site substituent and warheads combined with a decahydroisoquinolin scaffold as a SARS 3CL protease inhibitor. |
| 000B93 (2019) |
Jin Hwa Kim [Corée du Sud] ; Minhee Kang [Corée du Sud] ; Eunkyoung Park [Corée du Sud] ; Doo Ryeon Chung [Corée du Sud] ; Jiyeon Kim [Corée du Sud] ; Eung Soo Hwang [Corée du Sud] | A Simple and Multiplex Loop-Mediated Isothermal Amplification (LAMP) Assay for Rapid Detection of SARS-CoV |
| 000C32 (2018) |
Liangzhong Lim [Singapour] ; Garvita Gupta [Singapour] ; Amrita Roy [Singapour] ; Jian Kang [Singapour] ; Shagun Srivastava [Singapour] ; Jiahai Shi ; Jianxing Song [Singapour] | Structurally- and dynamically-driven allostery of the chymotrypsin-like proteases of SARS, Dengue and Zika viruses |
